Target intelligence / Profile preview

Histone H1.2 (H1.2)

Target
H1.2
Molecular classification
Histone protein, Linker histone, Chromatin-associated protein, Epigenetic regulator, Other: Not a receptor, enzyme, transporter, or classical transcription factor
01

Overview

Histone H1.2 is a member of the linker histone H1 family, encoded by the HIST1H1C gene in humans[2]. It binds to linker DNA between nucleosomes and is essential for chromatin packaging into higher-order structures. Beyond its canonical role in chromatin compaction, H1.2 contributes to gene-specific silencing, especially in cancer, by recognizing the H3K27me3 epigenetic mark at tumor suppressor loci via its C-terminal tail, in cooperation with EZH2[1][4]. It also plays a key role in apoptotic signaling by translocating to the cytosol and activating Bak on the mitochondria after DNA damage, leading to cell death[2]. Furthermore, H1.2 regulates the DNA damage response by restraining ATM kinase activity on chromatin; H1.2 dissociation upon DNA damage (mediated by PARP1-dependent PARylation) allows ATM activation and DNA repair[3]. These diverse functions underscore H1.2 as a dynamic chromatin architectural protein with regulatory roles in transcription, genome stability, apoptosis, and disease pathogenesis, although it is not currently a clinical drug target.

Other names
H1.2H1-2H1F2HIST1H1CH1s-1H1cHistone H1cHistone H1dHistone cluster 1 H1 family member cHistone cluster 1, H1c
02

Mechanism of action

PARP inhibitors: May interfere with the PARylation-dependent displacement of H1.2 after DNA damage, affecting ATM activation. HDAC inhibitors: Induce chromatin relaxation which can affect H1.2 dissociation and ATM response. These mechanisms are *indirect* and not specific-targeted.

03

Biological functions

Chromatin compaction: Promotes higher-order chromatin structure by binding at nucleosome DNA entry/exit sitesGene silencing: Facilitates gene-specific transcriptional repression, especially of growth suppressive genesApoptosis modulation: Translocates to cytosol after DNA damage, activates pro-apoptotic factor Bak and promotes mitochondria outer membrane permeabilization, thereby contributing to apoptosisDNA damage response: Regulates ATM kinase activation and the DNA double-strand break response by acting as a chromatin barrier; its displacement is required for proper ATM signaling and repairRegulation of chromatin architecture and nucleosome stability: Involved in global changes in chromatin accessibility, influencing processes like transcription, replication, and repair
04

Disease associations

Cancer: Overexpression in cancer cells, contributes to gene silencing of tumor suppressorsDNA damage/repair-related disease: Involved in cellular responses to DNA damage and genome stabilityCell death/apoptosis-related disorders: Functions in apoptotic pathways via Bak activationOther roles have not been directly established for cardiovascular, infection, or neurodegenerative disease in current literature.
05

Safety considerations

Global chromatin compaction and gene silencing: Any direct targeting may non-specifically affect multiple genes, risking global transcriptional dysregulation.Genome instability risk: Manipulation (or depletion) of H1.2 may lead to aberrant DNA damage responses and potential chromatin destabilizationDue to central roles in chromatin, therapeutic targeting poses significant *safety and specificity challenges*.
06

Interacting drugs

None directly targeting Histone H1.2 are clinically approved or characterized. However, indirect drugs/modulators affecting chromatin (e.g., HDAC inhibitors, PARP inhibitors) may influence H1.2 dynamics
07

Biomarkers

H1.2 overexpression: Marker of certain cancers where gene silencing of suppressors is occurringChromatin compaction signature: Not used in standard patient selection, but H1.2 status may aid research in epigenetic profiling.

Beyond the preview

Go deeper on Histone H1.2 (H1.2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H1.2 (H1.2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call